Syner-G is proud to sponsor the 2026 Cell & Gene Meeting on the Mesa, one of the industry’s most important events bringing together innovators, investors, and decision-makers committed to advancing the future of cell and gene therapy.
As the sector continues to navigate the challenges of development, manufacturing, scale-up, and commercialization, Meeting on the Mesa provides a valuable forum for collaboration and knowledge sharing across the advanced therapies ecosystem.
Stacy Plum, PhD, SVP, CMC & Project Management and Head of Biologics, will represent Syner-G at this year’s event. Connect with Stacy to discuss strategies for accelerating development, strengthening operational readiness, and overcoming the complex CMC and commercialization challenges facing cell and gene therapy programs.
We look forward to engaging with industry leaders and contributing to the conversations driving the next generation of transformative therapies.
Attending Meeting on the Mesa?
About Stacy
Stacy M. Plum, Ph.D. is SVP of Pharmaceutical Development at Syner-G, bringing 30 years of biotechnology leadership focused on protein and cell-based therapeutics and vaccine development. Since joining Syner-G in 2021, she has advanced biologics programs from discovery through approval using risk-based, phase-appropriate strategies that accelerate development and strengthen regulatory submissions. Stacy has contributed to 20+ IND, IMPD, and BLA submissions, authored 15 scientific publications, 8 patents, and 20+ abstracts, with expertise spanning monoclonal antibodies, fusion proteins, bispecifics, ADCs, gene and cell therapies, and plasma protein therapeutics.
